1 – 3 of 3
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)
(
- Contribution to journal › Article
- 2014
-
Mark
Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer center.
(
- Contribution to journal › Article
- 2012
-
Mark
Bevacizumab in the treatment of ovarian cancer
(
- Contribution to journal › Scientific review